Pediatric Difficult Airway Prediction Using Ultrasonography

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT04361929
Collaborator
(none)
584
1
24.6
23.7

Study Details

Study Description

Brief Summary

Recognition of difficult airway is purported to be the most important factor in successful management of difficult airway. The incidence of difficult airway in pediatrics is much less than in adults; however, airway related complications can lead to hypoxic brain damage or even death especially in younger age groups as neonates and infants.The aim of this work is to evaluate the feasibility and accuracy of ultrasound measurements (hyomental distances, tongue measurements, and anterior neck soft tissue thickness at the level of hyoid bone, thyrohyoid membrane, and thyroid cartilage) in predicting difficult laryngoscopy and difficult mask ventilation in pediatric patients undergoing elective surgery under general anesthesia.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrasound

Study Design

Study Type:
Observational
Actual Enrollment :
584 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Pediatric Difficult Airway Prediction Using Ultrasonography
Actual Study Start Date :
Apr 26, 2020
Actual Primary Completion Date :
May 10, 2022
Actual Study Completion Date :
May 15, 2022

Outcome Measures

Primary Outcome Measures

  1. The sensitivity of DS-HB to predict difficult laryngoscopy [30 minutes]

    The ability of DS-HB ultrasound measurement to predict difficult airway in pediatrics

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Gender both males and females

  • ASA Class I and II

  • Age 1month to 10 years

  • Children undergoing elective surgery under general anaesthesia

Exclusion Criteria:
  • congenital upper airway malformation,

  • head and neck swellings,

  • scars,

  • radiation to the neck,

  • tracheotomy,

  • Neurosurgical or cardiac procedures

  • ENT surgeries

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kasr Al Ainy Cairo Egypt 11559

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Heba Nassar,MD, Associate professor, Cairo University
ClinicalTrials.gov Identifier:
NCT04361929
Other Study ID Numbers:
  • MS-259-2019
First Posted:
Apr 24, 2020
Last Update Posted:
Jul 20, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Heba Nassar,MD, Associate professor, Cairo University

Study Results

No Results Posted as of Jul 20, 2022